| | |
Any blood glucose-lowering drug (A10)
|
OAD (A10B)
|
Insulins only (A10A only)
|
|---|
|
Year
|
Person years
|
No of patients
|
Incidence rate per 100,000 person years
|
95% confidence interval
|
No of patients
|
Incidence rate per 100,000 person years
|
95% confidence interval
|
No of patients
|
Incidence rate per 100,000 person years
|
95% confidence interval
|
|---|
|
Women
| | | | | | | | | | |
|
2006
|
2,347,036
|
7,531
|
320
|
(314, 328)
|
6,752
|
288
|
(281, 295)
|
670
|
29
|
(26, 31)
|
|
2007
|
2,366,461
|
7,769
|
328
|
(321, 336)
|
6,927
|
293
|
(286, 300)
|
679
|
29
|
(27, 31)
|
|
2008
|
2,390,716
|
7,677
|
321
|
(314, 328)
|
6,717
|
281
|
(274, 288)
|
783
|
33
|
(31, 35)
|
|
2009
|
2,418,595
|
7,832
|
323
|
(317, 331)
|
6,912
|
286
|
(279, 293)
|
745
|
31
|
(29, 33)
|
|
2010
|
2,445,249
|
7,778
|
318
|
(311, 325)
|
6,817
|
279
|
(272, 286)
|
784
|
32
|
(30, 34)
|
|
2011
|
2,473,228
|
7,269
|
293
|
(287, 301)
|
6,369
|
258
|
(251, 264)
|
†
| | |
|
Men
| | | | | | | | | | |
|
2006
|
2,314,006
|
7,829
|
338
|
(331, 346)
|
6,830
|
295
|
(288, 302)
|
756
|
33
|
(30, 35)
|
|
2007
|
2,342,823
|
8,374
|
357
|
(350, 365)
|
7,326
|
313
|
(306, 320)
|
793
|
34
|
(32, 36)
|
|
2008
|
2,377,361
|
8,655
|
364
|
(356, 372)
|
7,498
|
315
|
(308, 323)
|
845
|
36
|
(33, 38)
|
|
2009
|
2,411,205
|
8,620
|
357
|
(350, 365)
|
7,453
|
309
|
(302, 316)
|
839
|
35
|
(33, 37)
|
|
2010
|
2,443,697
|
8,605
|
352
|
(345, 360)
|
7,475
|
306
|
(299, 313)
|
813
|
33
|
(31, 36)
|
|
2011
|
2,479,989
|
8,246
|
332
|
(325, 340)
|
7,131
|
288
|
(281, 294)
|
†
| | |
|
Total
| | | | | | | | | | |
|
2006
|
4,661,041
|
15,360
|
329
|
(324, 334)
|
13,582
|
291
|
(287, 297)
|
1,426
|
31
|
(29, 32)
|
|
2007
|
4,709,284
|
16,143
|
342
|
(338, 348)
|
14,253
|
303
|
(298, 308)
|
1,472
|
31
|
(30, 33)
|
|
2008
|
4,768,077
|
16,332
|
342
|
(337, 348)
|
14,215
|
298
|
(293, 303)
|
1,628
|
34
|
(33, 36)
|
|
2009
|
4,829,800
|
16,452
|
340
|
(335, 346)
|
14,365
|
297
|
(293, 302)
|
1,584
|
33
|
(31, 34)
|
|
2010
|
4,888,946
|
16,383
|
335
|
(330, 340)
|
14,292
|
292
|
(288, 297)
|
1,597
|
33
|
(31, 34)
|
|
2011
|
4,953,217
|
15,515
|
313
|
(308, 318)
|
13,500
|
273
|
(268, 277)
|
†
| | |
-
*Incident use is defined as no use of blood glucose-lowering drugs in the previous 24 months. In addition, for insulins only no OAD was dispensed in the subsequent 12 months.
-
†For insulins only users there are no data for 2011 due to the definition applied, requiring a 12 month follow up period after first insulin prescription filled.
